1.Research progress on the molecular genetic mechanism of Parkinson's disease.
Chinese Journal of Medical Genetics 2026;43(2):151-157
The pathogenesis of Parkinson's disease is closely related to genetic factors. This article has systematically reviewed the research progress of molecular genetic mechanism on Parkinson's disease by focusing on the role of six high-penetrance pathogenic genes (SNCA, LRRK2, PRKN, PINK1, PARK7, and VPS35) and some risk genes (such as GBA1). These genetic variants eventually converge in three core pathogenic biological pathways, including lysosomal-autophagy pathway disorder, mitochondrial quality control disorder and α-synuclein metabolic abnormality. In-depth understanding of these molecular mechanisms is of great significance for the development of targeted therapy and realization of precision medicine for this disease.
Humans
;
Parkinson Disease/metabolism*
;
alpha-Synuclein/genetics*
;
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/genetics*
;
Genetic Predisposition to Disease
;
Protein Kinases/genetics*
;
Animals
;
Glucosylceramidase/genetics*
;
Ubiquitin-Protein Ligases/genetics*
2.Efficacy and Safety of Pre-Endoscopy Regimens for Mucosal Visualization During Sedated Esophagogastro-duodenoscopy: A Randomized Controlled Trial
Fauzi Yusuf ; Azzaki Abubakar ; Desi Maghfirah
Acta Medica Indonesiana 2026;58(1):5-14
Abstract
Background: Optimal mucosal visibility during esophagogastroduodenoscopy (EGD) is critical for diagnostic accuracy but is often impaired by the presence of mucus and bubbles. This study aimed to compare the efficacy and safety of four premedication regimens for mucosal visualization during sedated EGD. Methods: A double-blind randomized controlled trial was conducted at the Endoscopy Unit of Dr. Zainoel Abidin General Hospital, Banda Aceh, Indonesia, from January to December 2024. Patients scheduled for elective diagnostic EGD were randomly assigned to: Group 1 (simethicone 40 mg at 30 minutes before the procedure), Group 2 (simethicone 40 mg + 100 mL 5% sodium bicarbonate at 2 hours), Group 3 (simethicone 40 mg + N-acetylcysteine 600 mg in 100 mL water at 2 hours), or Group 4 (all three agents at 2 hours). Primary outcomes were mucosal visibility (6-site, 3-point scoring system with lower scores indicating superior mucosal visibility); procedural metrics (irrigation volume and duration); and safety (the lowest recorded SpO₂%). Data were analyzed using ANOVA or Kruskal–Wallis for continuous variables, and Chi-square or Fisher’s exact test for categorical variables, with post hoc testing as applicable. Results: A total of 168 patients were randomized into four groups (n=42 each). Groups 3 and 4 showed superior mucosal visibility compared to Groups 1 and 2 (p=0.004), with no significant difference between Groups 3 and 4. Irrigation volume differed significantly (p=0.018), lowest in Group 4. Group 3 had the shortest procedure time (3.1 ± 1.2 minutes), significantly more efficient than Groups 1 and 2, but similar to Group 4. Oxygen saturation was slightly lower in Group 3 (p<0.005), though all groups remained within safe clinical limits. Conclusions: Simethicone and N-acetylcysteine given two hours before endoscopy effectively enhanced mucosal visibility and procedural efficiency without compromising safety, offering a practical alternative to more complex regimens.
esophagogastroduodenoscopy
;
mucosa visibility
;
premedication
;
simethicone
;
N-acetylcysteine
3.The role of free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis: A cross-sectional study
Menon Saieehwaran ; Sy Liang Yong ; Vijiya Mala Velayutham ; Jason Tan Seng Hong ; Avni Patel ; Zienna Zufida binti Zainol Rashid ; Hanisah Abdul Hamid ; Salbiah binti Mohd Isa ; Li Vern Lim
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):11-
Introduction:
Accurate diagnosis of thyrotoxicosis, a condition resulting from excessive thyroid hormone activity, is essential for
appropriate management. However, access to diagnostic tools such as thyrotropin receptor antibody (TRAb) assays
and thyroid ultrasonography remains limited in resource-constrained settings, highlighting the need for cost-effective
alternatives. Recent studies suggest that the free triiodothyronine to free thyroxine (FT3/FT4) ratio may serve as a potential
biomarker for differentiating the causes of thyrotoxicosis.
Methodology:
This cross-sectional study evaluated the FT3/FT4 ratio in newly diagnosed thyrotoxicosis patients aged ≥18 years recruited
from Hospital Tengku Ampuan Rahimah, Hospital Banting, Klinik Kesihatan Pelabuhan Klang, and Klinik Kesihatan
Pandamaran between February and December 2025. All participants underwent thyroid function testing (FT3, FT4, and
TSH) and autoantibody assessment (TRAb and anti-thyroid peroxidase [anti-TPO]). Diagnostic performance of the FT3/FT4
ratio for Graves’ disease was assessed using receiver operating characteristic (ROC) curve analysis.
Results:
Fifty-eight patients were included, of whom 58.6% were diagnosed with Graves’ disease. Patients with Graves’ disease had
significantly higher FT3 levels (median 16.8 pmol/L; IQR 10.9–25.7) compared to those with non-Graves’ thyrotoxicosis
(median 8.3 pmol/L; IQR 5.3–13.5; p <0.001), with similar trends observed for FT4 levels (p <0.001). However, the FT3/
FT4 ratio did not differ significantly between groups (p >0.05), with an overall ROC AUC of 0.572, indicating poor
discriminatory ability. Subgroup analysis based on FT4 levels improved performance; at FT4 <30 pmol/L, the FT3/FT4
ratio demonstrated 75.0% sensitivity, 91.7% specificity, and 87.5% diagnostic accuracy at a cutoff of 0.3445 (AUC = 0.813;
95% CI: 0.570–1.000; p = 0.069). No significant association was observed between the FT3/FT4 ratio and TRAb or anti-TPO.
Conclusion
The FT3/FT4 ratio has limited overall diagnostic utility but may provide adjunctive value in selected biochemical
contexts, particularly in settings with limited access to immunological testing.
Diagnosis, Differential
;
Thyroxine
;
Triiodothyronine
;
Thyrotoxicosis
;
Cross-Sectional Studies
4.The dopamine dilemma: Exogenous L-DOPA or rare dopaminoma?
Amal Hanani Abdul Halim ; Farhi Ain Jamaluddin
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):22-23
Introduction:
Dopaminomas or dopamine-secreting pheochromocytomas
are rare neuroendocrine tumors that frequently lack the
classic paroxysmal symptoms of catecholamine excess
(headache, sweating, palpitation). Diagnosing these tumors
is exceptionally challenging when biochemical markers—
specifically markedly elevated urinary dopamine—are
interpreted in patients receiving exogenous Levodopa
(L-DOPA) therapy, as the intake obscures clinical
significance.
Case:
A 76-year-old male with ischemic heart disease, stage 4
chronic kidney disease, and new-onset hypertension was
admitted for acute cholecystitis. Imaging studies incidentally revealed bilateral adrenal masses and demonstrated
lipid-rich characteristics upon further evaluation with
computed tomography (CT) adrenal washout. Biochemical
evaluation revealed extreme elevations in 24-hour urinary
dopamine (47,534 nmol/24 hours; normal <3,237) and
3-methoxytyramine (18.93 µmol/24 hours; normal <2.60),
whereas downstream urinary noradrenaline (5.0 nmol/24
hours; normal 71.5–505.3), adrenaline (4.0 nmol/24 hours;
normal 9.2–122.3), normetanephrine (0.22 µmol/24 hours;
normal 0.88–2.88), and metanephrine (0.25 µmol/24 hours;
normal 0.33–1.53) levels were all significantly below their
respective reference ranges. The diagnosis was complicated
by the patient’s concurrent use of L-DOPA/Benserazide
for flupentixol-induced parkinsonism. L-DOPA is a direct
precursor to dopamine; its administration can cause
massive, false-positive elevations in urinary dopamine,
mimicking a dopaminoma’s biochemical signature.
However, the unique combination of profoundly high
dopamine alongside suppressed downstream catecholamines and metanephrines suggested a true dopaminesecreting tumor—potentially secondary to dopamine
beta-hydroxylase (DBH) deficiency—rather than drug
interference.
Conclusion
This case illustrates the profound difficulty in diagnosing
dopaminoma when exogenous L-DOPA therapy creates a
near-identical biochemical profile. The diagnostic dilemma
is further amplified by vague symptomatology, multiple
comorbidities, and non-suggestive imaging. However,
the finding of isolated dopamine hypersecretion with
suppressed metanephrines serves as a critical clinical clue.
This pattern points toward an intratumoral biosynthetic
defect rather than drug interference. Clinicians must
maintain a high index of suspicion and perform meticulous
biochemical fractionation to identify these rare, dopamineisolated secreting tumors.
Dopamine
;
Levodopa
5.Safety and Clinical Outcomes of Ramadan Fasting in Patients with Arginine Vasopressin Deficiency: A Retrospective Cohort Study
Suprhamanyam Evali ; Nur Arina binti Mohammed Zain ; Nao Chang Zhao ; Noor Ashikin binti Ismail ; Dineash Kumar Kannesan ; Nurain binti Mohd Noor
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):80-81
Introduction:
Arginine vasopressin deficiency (AVP-D) is characterized
by impaired antidiuretic hormone secretion, leading to
polyuria and a significant dehydration risk. The British
Islamic Medical Association classifies AVP-D as a “very
high risk” condition, advising against Ramadan fasting. However, many patients fast due to religious convictions,
creating a gap between clinical guidelines and patient
practice. This study evaluates the clinical outcomes and
safety of fasting in this population.
Methodology:
A single-centre retrospective cohort study was conducted
at Hospital Putrajaya. We included adults with
permanent AVP-D on desmopressin therapy for more
than 1 year who fasted during Ramadan 2025. Data were
extracted from electronic medical records and patient
consultations. Primary outcomes included hospitalization
rates, dehydration symptoms, and desmopressin dose
adjustments.
Results:
Of the 43 patients (mean age 42.4 ± 15.28 years; 53.5%
female), 27 successfully fasted for a mean of 27.6 ± 6.56
days. Pre-Ramadan counseling was documented in only
55.8% of cases. While 25.9% of participants experienced
dehydration symptoms (thirst, dizziness), and 22.2% broke
their fast for safety reasons, there were no hospitalizations.
None of the patients required additional desmopressin
dose adjustments. Most patients (66.7%) maintained twicedaily desmopressin dosing (Sahur and Iftar). Anterior
pituitary deficiencies were present in 70.3% of the cohort.
Conclusion
Despite being classified as very high risk, many AVP-D
patients safely complete Ramadan fasting without severe
adverse events. However, the high rate of dehydration
symptoms and the significant gap in pre-Ramadan
counseling (44.2% un-counseled) highlight the need for
structured clinical reviews 4–6 weeks prior to Ramadan to
optimize hydration and dosing
Humans
;
Diabetes Insipidus, Neurogenic
;
Retrospective Studies
;
Arginine
;
Fasting
6.Etiological Yield and Treatment Patterns in Paediatric Arginine Vasopressin Deficiency: A Single-Centre Cohort Study
Siti Sarah Ahmad Dardiri ; Nalini M Selveindran ; Sok Bee Lim ; Arini Nuran Md Idris ; Janet YH Hong
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):125-
Introduction:
Arginine vasopressin deficiency (AVP‑D), previously termed central diabetes insipidus, is a rare paediatric endocrine
disorder that may present as an early manifestation of diverse hypothalamic–pituitary conditions. Identifying the
underlying etiology is crucial for guiding management and surveillance; however, in some children, the cause remains
unresolved, leading to primarily symptomatic treatment. In Malaysia, published literature on paediatric AVP‑D has been
limited to isolated case reports, with no cohort‑level data available. This study aims to describe the clinical features,
etiological spectrum, and treatment patterns of paediatric AVP-D in a single-centre Malaysian cohort, emphasizing
diagnostic yield, unresolved causes, and the central role of neuroimaging.
Methodology:
A retrospective review was conducted of children diagnosed with AVP-D. Data collected included age at symptom onset,
age at presentation, clinical features, etiological classification, neuroimaging findings, comorbidities, treatment modalities,
and follow-up outcomes. Descriptive statistics were used for analysis.
Results:
Twelve children were included, with a median age of 9.8 years; two-thirds were male. Children were referred at a median
age of 3.4 years, with presentation ranging from the neonatal period to 10.4 years. Diagnostic delay was minimal overall,
although 25% experienced delays exceeding 1 year. The water deprivation test was performed in 33.3% of patients.
Magnetic resonance imaging (MRI) was completed in all children and served as the principal determinant of etiology.
Structural abnormalities were identified in 50% of the cohort, including semilobar holoprosencephaly (33.3%), Arnold–
Chiari I malformation (8.3%), and pituitary stalk interruption syndrome (8.3%). The posterior pituitary bright spot was
absent in most patients, and 50% required repeat MRI to clarify evolving neurohypophyseal features. Tumor-related AVP-D
accounted for 8.3%, while one-third had no definitive etiology despite imaging. Initial therapy included desmopressin
(58.3%), hydrochlorothiazide (25%), and diluted sublingual desmopressin (8.3%), with most requiring dose escalation.
Growth impairment occurred in 66.7% of patients, and delayed puberty in 16.7%.
Conclusion
MRI played a central role in defining etiology, with half of the cohort demonstrating congenital structural abnormalities.
Persistent unresolved cases highlight the diagnostic challenges of AVP-D and underscore the importance of early MRI
and longitudinal endocrine follow-up.
Child
;
Cohort Studies
;
Diabetes Insipidus, Neurogenic
;
Arginine
7.Efficacy of N-acetylcysteine plus beta-blocker versus beta-blocker alone in preventing postoperative atrial fibrillation after cardiac surgery: A meta-analysis of randomized controlled trials
Giovanni Vista ; Von Jerick B. Tenorio ; Marivic V. Vestal
Philippine Journal of Cardiology 2025;53(1):73-86
BACKGROUND
Postoperative atrial fibrillation (POAF) is the most common arrythmia to occur after cardiovascular surgery. Inflammation being pivotal in POAF perpetuation has been utilized as a therapeutic target. Owing to their anti-inflammatory and anti-oxidant effects, beta-blockers (BB) and N-acetylcysteine (NAC) became research interests in the pursuit for an effective POAF prevention strategy.
OBJECTIVETo determine the efficacy of NAC plus BB versus BB alone in preventing POAF in cardiac surgery patients.
METHODOLOGYA literature search using the following search engines: PubMed/Medline, Cochrane Review Central, Clinical Trials Registry, ResearchGate, Mendeley and Google Scholar for relevant randomized trials were conducted. Published and unpublished studies indexed from inception until 2023 were included. Three independent reviewers evaluated the randomized clinical trials (RCTs) for eligibility. The pooled estimates for POAF prevention as primary outcome and MACE, mortality, myocardial infarction, stroke, ICU LOS and hospital LOS as secondary outcomes were measured using the RStudio statistical software.
RESULTSSeven eligible RCTs allocated 1069 cardiac surgery patients to NAC + BB (n=539) and BB alone (N = 530) treatment arms. The effect estimate using random effect model disclosed significantly reduced POAF events (RR 0.62, 95% CI [0.44, 0.86], p = 0.005) in those on NAC + BB. While no statistical difference between the study arms were demonstrated in reducing mortality (RR 0.63, 95% CI [0.23, 1.73], p = 0.37); myocardial infarction (RR 1.02, 95% CI [0.49, 2.13], p = 0.96); stroke (RR 0.95, 95% CI [0.24, 3.68], p = 0.94); ICU LOS (std. mean difference 0.14, 95% CI [-0.43, 0.70], p = 0.41), and hospital LOS (std. mean difference 0.08, 95% CI [-0.06, 0.21], p = 0.19).
CONCLUSIONAmong cardiac surgery patients, the use of NAC in combination with BB compared with BB alone significantly reduced POAF.
Acetylcysteine ; Arrhythmias, Cardiac ; Atrial Fibrillation ; Myocardial Infarction ; Omega-chloroacetophenone
8.WNK1 Alleviates Chloride Efflux-Induced NLRP3 Inflammasome Activation and Subsequent Neuroinflammation in Early Brain Injury Following Subarachnoid Hemorrhage.
Panpan ZHAO ; Huimiao FENG ; Xinyu ZHOU ; Jingyuan ZHOU ; Fangbo HU ; Taotao HU ; Yong SUN
Neuroscience Bulletin 2025;41(9):1570-1588
The nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome plays a crucial role in the prognosis of subarachnoid hemorrhage (SAH). WNK1 kinase negatively regulates NLRP3 in various inflammatory conditions, but its role in early brain injury (EBI) after SAH remains unclear. In this study, we used an in vivo SAH model in rats/mice and AAV-WNK1 intraventricular injection to investigate its neuroprotective mechanisms. WNK1 expression was significantly reduced in SAH patient blood and SAH model brain tissue, correlating negatively with microglial activation. AAV-WNK1 alleviated brain edema, neuronal necrosis, behavioral deficits, and inflammation by inhibiting NLRP3 inflammasome activation. In hemin-stimulated BV-2 cells, WNK1 overexpression reduced NLRP3 activation and inflammatory cytokines. Chloride counteracted WNK1's inhibitory effects, and WNK1 suppressed P2X7R-induced NLRP3 activation. Mechanistically, WNK1 functioned via the OXSR1/STK39 pathway. These findings highlight WNK1 as a key regulator of intracellular chloride balance and neuroinflammation, presenting a potential therapeutic target for SAH treatment.
Animals
;
NLR Family, Pyrin Domain-Containing 3 Protein/metabolism*
;
Subarachnoid Hemorrhage/complications*
;
Inflammasomes/metabolism*
;
Rats
;
Mice
;
Neuroinflammatory Diseases/metabolism*
;
WNK Lysine-Deficient Protein Kinase 1/genetics*
;
Male
;
Humans
;
Chlorides/metabolism*
;
Mice, Inbred C57BL
;
Rats, Sprague-Dawley
;
Brain Injuries/metabolism*
;
Microglia/metabolism*
;
Protein Serine-Threonine Kinases
9.Programmed death-ligand 1 regulates ameloblastoma growth and recurrence.
Linzhou ZHANG ; Hao LIN ; Jiajie LIANG ; Xuanhao LIU ; Chenxi ZHANG ; Qiwen MAN ; Ruifang LI ; Yi ZHAO ; Bing LIU
International Journal of Oral Science 2025;17(1):29-29
Tumor cell-intrinsic programmed death-ligand 1 (PD-L1) signals mediate tumor initiation, progression and metastasis, but their effects in ameloblastoma (AM) have not been reported. In this comprehensive study, we observed marked upregulation of PD-L1 in AM tissues and revealed the robust correlation between elevated PD-L1 expression and increased tumor growth and recurrence rates. Notably, we found that PD-L1 overexpression markedly increased self-renewal capacity and promoted tumorigenic processes and invasion in hTERT+-AM cells, whereas genetic ablation of PD-L1 exerted opposing inhibitory effects. By performing high-resolution single-cell profiling and thorough immunohistochemical analyses in AM patients, we delineated the intricate cellular landscape and elucidated the mechanisms underlying the aggressive phenotype and unfavorable prognosis of these tumors. Our findings revealed that hTERT+-AM cells with upregulated PD-L1 expression exhibit increased proliferative potential and stem-like attributes and undergo partial epithelial‒mesenchymal transition. This phenotypic shift is induced by the activation of the PI3K-AKT-mTOR signaling axis; thus, this study revealed a crucial regulatory mechanism that fuels tumor growth and recurrence. Importantly, targeted inhibition of the PD-L1-PI3K-AKT-mTOR signaling axis significantly suppressed the growth of AM patient-derived tumor organoids, highlighting the potential of PD-L1 blockade as a promising therapeutic approach for AM.
Ameloblastoma/metabolism*
;
Humans
;
B7-H1 Antigen/metabolism*
;
Neoplasm Recurrence, Local/pathology*
;
Signal Transduction
;
Cell Proliferation
;
Up-Regulation
;
TOR Serine-Threonine Kinases/metabolism*
;
Proto-Oncogene Proteins c-akt/metabolism*
;
Telomerase/metabolism*
;
Jaw Neoplasms/metabolism*
;
Epithelial-Mesenchymal Transition
;
Animals
;
Cell Line, Tumor
;
Female
;
Male
10.Arginine modulates the pH, microbial composition, and matrix architecture of biofilms from caries-active patients.
Yumi C DEL REY ; Pernille D RIKVOLD ; Marie B LUND ; Eero J RAITTIO ; Andreas SCHRAMM ; Rikke L MEYER ; Sebastian SCHLAFER
International Journal of Oral Science 2025;17(1):70-70
The caries-preventive effects of arginine have been attributed to its impact on biofilm composition and pH. Recent in vitro studies suggest that arginine also affects the production of biofilm matrix components that contribute to virulence, but this mechanism has not been investigated clinically. This randomized, placebo-controlled, triple-blind, split-mouth in situ trial assessed arginine's impact on the microbial composition, matrix architecture, and microscale pH of biofilms from caries-active patients (N = 10). We also examined whether individual differences in the pH response to arginine were related to biofilm composition and matrix structure. Biofilms were grown for four days on carriers attached to intraoral splints. Three times daily, the biofilms were treated extraorally with sucrose (5 min), followed by arginine or placebo (30 min), in a split-mouth design. After growth, the microscale biofilm pH response to sucrose was monitored by pH ratiometry. Microbial biofilm composition and carbohydrate matrix architecture were analyzed by 16S rRNA gene sequencing and fluorescence lectin-binding analysis, respectively. Arginine treatment significantly mitigated sucrose-induced pH drops, reduced total carbohydrate matrix production, and altered the spatial distribution of fucose- and galactose-containing carbohydrates. Both arginine- and placebo-treated biofilms were dominated by streptococci and Veillonella spp. Paired analyses showed a significant reduction in mitis/oralis group streptococci and a non-significant increase in several arginine metabolizers in arginine-treated biofilms. Individual pH responses were not significantly associated with the abundance of specific bacterial taxa or carbohydrate matrix components. In conclusion, arginine reduced the virulence of biofilms from caries-active patients through multiple mechanisms, including suppressing matrix carbohydrate production.
Biofilms/drug effects*
;
Humans
;
Arginine/pharmacology*
;
Hydrogen-Ion Concentration
;
Dental Caries/prevention & control*
;
Male
;
Female
;
Adult
;
Double-Blind Method
;
Sucrose/pharmacology*


Result Analysis
Print
Save
E-mail